The USA and the United Kingdom have agreed to eliminate tariffs on pharmaceutical products, in exchange for increasing British spending on medicines through the NHS.
Raluca Ioana Draghici
International
www.shutterstock.com
Always see our news on Google
The United States has announced a trade agreement with the United Kingdom that eliminates tariffs on pharmaceutical products and medical technologies. In return, the United Kingdom will increase the percentage of the NHS budget allocated to medications and will pay 25% more for new drugs. The agreement aims to stimulate investment and innovation in both countries, according to U.S. Trade Representative Jamieson Greer. A change in the assessment of therapy value by NICE is also expected, which will modify the threshold used to determine the effectiveness of medications. The U.S. has pressured the UK to pay more for American drugs, and the pharmaceutical industry has expressed dissatisfaction with the conditions in the United Kingdom. London has committed to reducing the reimbursement rate to 15% starting in 2026.
Sources
Latest News
22:59
SpaceX intends to develop a new major center for the Starship program in Louisiana, with an estimated investment of 100 billion dollars.
22:54
Nicușor Dan has notified the Constitutional Court regarding the unconstitutionality of the Decarbonization Law of the energy sector, which affects Romania's obligations in the field of environmental protection.
22:43
Kelemen Hunor, about the failure of the Salary Law: "Such a decision cannot be made responsibly in just a few days. We are not legislating for the European Commission."
22:23
President Nicușor Dan will have meetings on Thursday with Maia Sandu and Volodymyr Zelensky in Chișinău, on the occasion of the Independence Day of the Republic of Moldova
22:07
Dragoș Pîslaru and Radu Miruță accuse PSD of sabotaging the negotiations for the Salary Law and the loss of 770 million euros from PNRR
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
